45 Results

People

  1. Hsu
    Hsu
  2. Giralt
    Giralt
  3. Koehne
    Koehne
  4. Perales
    Perales
  5. Van Den Brink
    Van Den Brink
  6. Devlin
    Devlin
  7. Landau
    Landau
  8. Young
    Young
  9. O'Reilly
    O'Reilly
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (45)
  2. Department of Medicine (45)
  3. Hematologic Malignancies Research (45)
  4. Bone Marrow Transplant (40)
  5. GSK Faculty (35)
  6. Hematologic Malignancies, Division of (34)
  7. Human Oncology and Pathogenesis Program (26)
  8. Tow Center for Developmental Oncology (TCDO) (25)
  9. Survivorship Research (23)
  10. Sloan Kettering Institute Faculty (19)
  1. "Hematologic Malignancies Research"
  2. "Biology of Blood and Marrow Transplantation"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (45)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Department of Medicine (45)
  3. Hematologic Malignancies Research (45)
  4. Bone Marrow Transplant (40)
  5. GSK Faculty (35)
  6. Hematologic Malignancies, Division of (34)

More Groups

People
  1. Katharine Hsu (22)
  2. Sergio Giralt (18)
  3. Marcel Van Den Brink (15)
  4. Guenther Koehne (13)
  5. Miguel-Angel Perales (13)
  6. Sean Devlin (12)

More People

Years
  1. 2020 (7)
  2. 2019 (6)
  3. 2018 (2)
  4. 2017 (2)
  5. 2016 (2)
  6. 2015 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (45)
Publishers
  1. Elsevier Inc. (45)

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Potent synergy between combination of chimeric antigen receptor (CAR) therapy targeting CD19 in conjunction with dendritic cell (DC)/tumor fusion vaccine in hematological malignancies
    Meeting Abstract

    Capelletti, M.; Liegel, J.; Themeli, M.; Mutis, T.; Stroopinsky, D.; Orr, S.; Torres, D.; Morin, A.; Gunset, G.; Ghiasuddin, H.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save